DexCom (DXCM) : The value of composite uptick trades was $16.83 million, whereas, the value of composite downtick trades was $20.21 million. The uptick to downtick ratio stood at 0.83 with a negative money flow of ($3.39) Million during Mondays trading session. The block trades money flow was negative ($1.89 million).The uptick to the downtick ratio of 0.52 in block trades signals that the large investors have utilized the rise in the stock to sell.The uptick transaction value stood at $2.08 million. The transaction of the trades on downticks amounted to $3.98 million, which confirms investors selling on the strength of price. DexCom (DXCM) gained 67 cents at $78.22, an increase of 0.86% over the previous days close.
DexCom, Inc. is up 15.56% in the last 3-month period. Year-to-Date the stock performance stands at -4.53%. DexCom, Inc. has dropped 1.52% in the last five trading days, however, the shares have posted positive gains of 7.86% in the last 4 weeks. In a related news, Balo Andrew K, officer (EVP, Clinical and Regulatory) of Dexcom Inc, unloaded 5,000 shares at an average price of $80.12 on July 13, 2016. The total amount of the transaction was worth $400,600, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
DexCom (NASDAQ:DXCM): stock turned positive on Monday. Though the stock opened at $78.3, the bulls momentum made the stock top out at $78.52 level for the day. The stock recorded a low of $76.76 and closed the trading day at $78.19, in the green by 0.83%. The total traded volume for the day was 1,190,819. The stock had closed at $77.55 in the previous days trading.
Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers for the treatment of people with and without diabetes. Its products consist of DexCom G4, DexCom G4 PLATINUM and DexCom Share System. The DexCom G4 PLATINUM with Share uses a wireless connection between a patients receiver and an application on the patients iPhone to transmit glucose information to applications on the mobile devices of up to five designated recipients or followers, who can remotely monitor a patients glucose information and receive alert notifications anywhere they have an Internet connection. SweetSpots data transfer service is a Medical Device Data System (MDDS) and allows researchers to control the transfer of data from certain diabetes devices to research tools and databases according to their own research workflows.